[Teratogenic agents in man].
D000014:Abnormalities, Drug-Induced; D009008:Abnormalities, Severe Teratoid; D000728:Androgens / Q000009:adverse effects; D000777:Anesthetics / Q000009:adverse effects; D000900:Anti-Bacterial Agents / Q000009:adverse effects; D000970:Antineoplastic Agents / Q000009:adverse effects; D002869:Chromosome Aberrations; D025063:Chromosome Disorders; D000013:Congenital Abnormalities / Q000196:embryology / Q000209:etiology* / Q000517:prevention & control; D003348:Cortisone / Q000009:adverse effects; D012734:Disorders of Sex Development; D005260:Female; D005333:Fetus / Q000528:radiation effects; D006801:Humans; D007231:Infant, Newborn; D008431:Maternal-Fetal Exchange; D009748:Nutrition Disorders / Q000150:complications*; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious; D012409:Rubella; D013449:Sulfonamides / Q000009:adverse effects; D014777:Virus Diseases / Q000150:complications*
D000728:Androgens; D000777:Anesthetics; D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D013449:Sulfonamides; D003348:Cortisone
Les agents tératogènes chez l'homme.